222.20
West Pharmaceutical Services Inc (WST) 最新ニュース
How Is The Market Feeling About West Pharmaceutical Servs? - Benzinga
WST ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your West Pharmaceutical Services, Inc. investment - ACCESS Newswire
West Pharmaceutical Services, Inc. (WST) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights - ACCESS Newswire
West Pharmaceutical Services, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud AllegationsWST - ACCESS Newswire
Unpacking Q4 Earnings: West Pharmaceutical Services (NYSE:WST) In The Context Of Other Drug Development Inputs & Services Stocks - Yahoo Finance
West Pharmaceutical Services (NYSE:WST) Proposes Bylaw Changes; Share Price Remains Flat - Yahoo Finance
Is West Pharmaceutical Services Stock Underperforming the S&P 500? - Nasdaq
Is West Pharmaceutical Services Stock Underperforming The S&P 500? - Barchart
West Pharmaceutical at KeyBanc Forum: Strategic Growth Amid Challenges - Investing.com
West Pharmaceutical at KeyBanc Forum: Strategic Growth Amid Challenges By Investing.com - Investing.com UK
UBS maintains Buy on West Pharma, reiterates $285 target By Investing.com - Investing.com Canada
UBS maintains Buy on West Pharma, reiterates $285 target - Investing.com
Did West Pharmaceutical Services, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate- WST - ACCESS Newswire
This West Pharmaceutical Services Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Benzinga India
Evercore ISI sets $275 target on West Pharmaceutical stock - Investing.com
Evercore ISI sets $275 target on West Pharmaceutical stock By Investing.com - Investing.com UK
Evercore ISI Initiates West Pharmaceutical Services at Outperform With $275 Price Target - Marketscreener.com
Managing Risks In Injectable Drug Delivery Solutions For Todays Drug Products And Tomorrows Novel Applications - BioProcess Online
West Pharmaceutical at Barclays Healthcare: Strategic Growth Amid Challenges - Investing.com India
West Pharmaceutical at Barclays Healthcare: Strategic Growth Amid Challenges By Investing.com - Investing.com South Africa
West Pharmaceutical Services, Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your RightsWST - ACCESS Newswire
On-Body Drug Delivery Devices Market to Hit $ 82.74 Bn by 2033Key - openPR
Jones Financial Companies Lllp Grows Stock Position in West Pharmaceutical Services, Inc. (NYSE:WST) - Defense World
West Pharmaceutical Announces Leadership Transition - TipRanks
Meeting Annex 1 Regulations: A Proactive Approach To Regulatory Compliance - Med Device Online
Lost Money on West Pharmaceutical Services, Inc. (WST)? You May Have Been Affected by FraudContact Levi & Korsinsky - ACCESS Newswire
West Pharmaceutical: Remains A Strong Long-Term Prospect (NYSE:WST) - Seeking Alpha
West Pharmaceutical Services to Present at Major 2025 Healthcare Conferences - MSN
Zacks Research Has Bearish Estimate for WST Q1 Earnings - Defense World
Why West Pharmaceutical Services, Inc. (WST) Is Plunging So Far In 2025 - Insider Monkey
A Look At The Intrinsic Value Of West Pharmaceutical Services, Inc. (NYSE:WST) - Yahoo Finance
FY2027 Earnings Forecast for WST Issued By Zacks Research - Defense World
West Pharmaceutical Services (NYSE:WST) Has A Pretty Healthy Balance Sheet - Simply Wall St
West to Participate in Upcoming Investor Conferences -March 05, 2025 at 06:01 am EST - Marketscreener.com
West to Participate in Upcoming Investor Conferences - Quantisnow
West Pharmaceutical Sets Key Investor Conference ScheduleHow to Access Their March Presentations - StockTitan
Lost Money on West Pharmaceutical Services, Inc.(WST)? You May Have Been Affected by FraudContact Levi & Korsinsky - ACCESS Newswire
Private Advisor Group LLC Trims Position in West Pharmaceutical Services, Inc. (NYSE:WST) - Defense World
Achieving EU GMP Annex 1 Compliance Through An End-To-End Approach To Contamination Control - Med Device Online
West Pharmaceutical Services, Inc. (NYSE:WST) Receives $344.00 Consensus Target Price from Brokerages - Defense World
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MSN
West Pharmaceutical's Long-Term Growth Intact, but Margin Expansion Less Uncertain - Morningstar
Do Wall Street Analysts Like West Pharmaceutical Services Stock? - MSN
Levi & Korsinsky Investigates Possible Securities Fraud Violations by West Pharmaceutical Services, Inc. (WST) - ACCESS Newswire
Healthcare Visual Inspection Services Market Report, 2030 - Grand View Research
West Pharmaceutical Services, Inc. (NYSE:WST) Shares Sold by Allspring Global Investments Holdings LLC - Defense World
West Pharmaceutical Services Declares $0.21 Dividend for Q2 2025 - MSN
West Pharmaceutical Services: How GLP-1 and Biologics Are Unlocking Explosive Growth! - Smartkarma
大文字化:
|
ボリューム (24 時間):